ctDNA-NGS Assay (Liquid Biopsy) for Non-Small Cell Lung Cancer: Utility of Plasma Cell-Free DNA and Tissue NGS in Detecting Genetic Mutations

被引：0
|
作者：
Papadakis, A. [1 ]
Kasymjanova, G. [2 ]
Spatz, A. [1 ]
Cohen, V. [2 ]
Pepe, C. [2 ]
Sakr, L. [2 ]
Merza, R. [1 ]
Agulnik, J. [2 ]
机构：
[1] Lady Davis Inst Med Res, Montreal, PQ, Canada
[2] Jewish Gen Hosp, Montreal, PQ, Canada
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.06D.08
引用
收藏
页码：S325 / S325
页数：1
相关论文
共 50 条
  • [41] Detecting Cancer Related Mutations in Cell-Free DNA of Lung Cancer Patients
    Tamm, Madli
    Oselin, Kersti
    Kivistik, Paula Ann
    Kals, Mart
    Keerma, Katrin
    Roosipuu, Retlav
    Leismann, Tiina
    Roomere, Hanno
    Metspalu, Andres
    Tonisson, Neeme
    HUMAN HEREDITY, 2016, 81 (04) : 227 - 227
  • [42] Comparison of plasma to tissue DNA mutations in surgical patients with non-small cell lung cancer Discussion
    Schrump, D.
    Chen, Kezhong
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2017, 154 (03): : 1130 - +
  • [43] Faster Treatment Decision-Making Using Liquid Biopsies NGS in Non-Small Cell Lung Cancer
    Huynh, C. B.
    Brice, K.
    Tsai, J.
    Dumais, K.
    Almuinas, S.
    Carracedo, C. E.
    Musleh, S. E.
    Theik, N. E.
    Izquierdo, P. E.
    Alvarez, A. E.
    Drusbosky, L.
    Raez, L. E.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S326 - S327
  • [44] Circulating cell-free DNA as a prognostic and predictive biomarker in non-small cell lung cancer
    Ai, Bo
    Liu, Huiquan
    Huang, Yu
    Peng, Ping
    ONCOTARGET, 2016, 7 (28) : 44583 - 44595
  • [45] Dynamics of methylated cell-free DNA in the urine of non-small cell lung cancer patients
    Bach, Sander
    Wever, Birgit M. M.
    van de Wiel, Mark A.
    Veltman, Joris D.
    Hashemi, Sayed M. S.
    Kazemier, Geert
    Bahce, Idris
    Steenbergen, Renske D. M.
    EPIGENETICS, 2022, 17 (10) : 1057 - 1069
  • [46] Efficacy of liquid biopsy for genetic mutations determination in non-small cell lung cancer: a systematic review on literatures
    Mohammad Mehdi Jahani
    Parisa Mashayekhi
    Mir Davood Omrani
    Azita Azimi Meibody
    BMC Cancer, 25 (1)
  • [47] Highly Sensitive Sel-Cap™ Lung Cancer Panel NGS for Detection of Tumor-Derived EGFR Mutations in Plasma Cell-Free DNA in Lung Cancer
    Shin, J.
    Kim, J.
    Lee, M.
    Kim, M.
    Lee, H.
    Park, H. K.
    Kim, S. R.
    Kim, J.
    Kang, J. H.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S700 - S700
  • [48] EGFR mutation detection in plasma cell-free DNA correlates with clinical outcomes in non-small cell lung cancer
    Shi, J.
    Mong, J.
    Chin, T. M.
    Lim, Y. H.
    Tan, W. L.
    Toh, C. K.
    Tan, H. S.
    Wong, S-W.
    Tee, A.
    Chan, D.
    Wong, K.
    Yeap, S.
    Ngo, L.
    Tan, Y-O.
    Tan, M-H.
    ANNALS OF ONCOLOGY, 2017, 28
  • [49] Plasma cell-free DNA integrity analyses for ovarian and non-small cell lung cancer patients with peptide vaccination
    Waki, Kayoko
    Yamada, Akira
    CANCER SCIENCE, 2018, 109 : 1273 - 1273
  • [50] Clinical validation of a sensitive real-time PCR assay for detecting EGFR mutations in plasma ctDNA from patients with non-small cell lung cancer
    Zhu, G.
    Li, Y.
    Jiang, F.
    VIRCHOWS ARCHIV, 2018, 473 : S289 - S289
12345